Trademark: 97427897
Word
INOVIQ
Status
Pending
Status Code
645
Status Date
Tuesday, March 12, 2024
Serial Number
97427897
Mark Type
3000
Filing Date
Wednesday, May 25, 2022

Trademark Owner History

Classifications
5 Pharmaceutical, biotechnology and medical preparations and substances for the prevention, diagnosis or treatment of cancer, neurodegenerative, cardiovascular, inflammatory, and metabolic diseases; diagnostic preparations and reagents for medical purposes; monoclonal antibodies for medical purposes; monoclonal antibody fragments for medical purposes; monoclonal antibody conjugates for medical purposes; preparations for the treatment, reconstruction and repair of cancer, neurodegenerative, cardiovascular, inflammatory, and metabolic diseases using antibodies or exosomes; immunological antibodies for medical use; biological preparations for the treatment of cancer, neurodegenerative, cardiovascular, inflammatory, and metabolic diseases for medical purposes; biological preparations for the treatment of cancer, neurodegenerative, cardiovascular, inflammatory, and metabolic diseases for pharmaceutical purposes; biological substances for the treatment of cancer, neurodegenerative, cardiovascular, inflammatory, and metabolic diseases for medical use; extracellular vesicles, RNA, protein arrays or monoclonal antibodies for diagnostic medical use; extracellular vesicles, RNA, protein arrays or monoclonal antibodies for medical use; extracellular vesicles or monoclonal antibodies for therapeutic purposes; products containing monoclonal antibodies for use in medicine; proteins for medical use in binding antibodies; proteins for medical use in detecting antibodies; reagents for use in the development of monoclonal antibodies for medical purposes; molecular targets and associated information for drug and vaccine development, all in the nature of biological reagents for medical purposes; tagged antibodies for medical use; vaccines; vaccines against cancer, viral or bacterial infection; vaccines for human use; vaccine adjuvants; diagnostic preparations, reagents, pharmaceutical and biochemical anti-cancer substances, products for the prevention, diagnosis or treatment of cancer, neurodegenerative, inflammatory, and metabolic diseases, and testing materials, namely, diagnostic test strips, immunoassays, PCR or genetic tests for in-vitro diagnostic use for medical purposes; diagnostic preparations and reagents for medical purposes, namely, diagnostic biomarker reagents for medical purposes; reagents for use in diagnostic tests for medical purposes; reagents for medical diagnosis research applications; recombinant human protein production cell line; protein arrays for use in recombinant DNA technology for medical diagnosis purposes; biological reagents for use in molecular biology for medical purposes; diagnostic preparations and reagents for medical purposes, namely, diagnostic reagents for in-vitro use for medical purposes, reagents for in-vitro laboratory use for medical purposes, reagents for use in diagnostic tests for medical purposes, diagnostic reagents for medical use for sale in kit form; reagents in kit form for conducting enzyme-linked immunosorbent assays (ELISA) for medical purposes; pharmaceutical, biotechnology and medical preparations and substances (for medical use or purposes), namely, immunotherapeutic agents for the treatment of cancer; nucleic acid substances for use in genetic probe assay kits for medical use; preparations for the treatment, reconstruction and repair of antibodies, namely, biological preparations for pharmaceutical purposes
1 Biological reagents for scientific and research use for molecular targets for drug and vaccine development; reagents for medical research applications; biological reagents for use in molecular biology for research purposes
44 Advisory services relating to medical diagnostic products; advisory services relating to medical diagnostic products, namely, medical diagnostic products for extracellular vesical (EV) isolations, creating custom NET builds, or developing diagnostic assays; Medical diagnostic testing services; medical diagnostic screening services in the field of diagnostic preparations
10 Biotechnology medical apparatus for the prevention, diagnosis or treatment of cancer, neurodegenerative, inflammatory, and metabolic diseases; medical diagnostic apparatus and instruments for testing biofluids, plasma, serum, saliva, urine and cell cultures for sale in kit form; biotechnology medical apparatus, namely, medical apparatus for the capture of extracellular vesicles
42 Scientific research, clinical research, development, advisory and consultancy services in relation to antibody production; drug discovery services; vaccine screening, in the nature of (or for) research and development of vaccines; advisory services relating to diagnostic products for scientific research, extracellular vesical (EV) isolations, creating custom NET builds, or developing diagnostic assays; providing testing and diagnostic services for others for scientific research purposes; medical research services; scientific research for medical purposes; scientific research for medical purposes, namely, research services relating to diagnostic products for scientific research, extracellular vesical (EV) isolations, creating custom NET builds, or developing diagnostic assays; pharmaceutical research services; diagnostic and research services and screening in the nature of research services in the field of diagnostic preparations; preparation of reports relating to medical, scientific and technical research; provision of information relating to medical, scientific and technical research; research and development of products; research and development of products, namely, new therapeutic products in the field of gene therapeutics and cell therapeutics; research and development of products, namely, extracellular vesicle-based diagnostic products, extracellular vesicle-based therapeutic products; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; laboratory research services relating to research in the field of extracellular vesicle-based diagnostics and extracellular vesicle-based therapeutics; scientific laboratory research and analysis services; scientific laboratory research and analysis services for research and analysis of new products in the field of cell therapeutics; analysis of tissues for medical research; research and development services in the field of antibody generation; molecular target discovery and development services; recombinant human protein production cell line, namely, culturing of cells for others for scientific research purposes
The mark consists of the wording "INOVIQ" to the right of a design of three concentric rings of dots.
Color is not claimed as a feature of the mark.

Trademark Events
Mar 12, 2024
Notification Of Final Refusal Emailed
Mar 12, 2024
Final Refusal E-Mailed
Mar 12, 2024
Final Refusal Written
Feb 12, 2024
Teas/Email Correspondence Entered
Feb 12, 2024
Correspondence Received In Law Office
Feb 12, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 12, 2024
Assigned To Lie
Sep 21, 2023
Teas Response To Office Action Received
Sep 21, 2023
Teas Voluntary Amendment Received
Jun 20, 2023
Application Extension Granted/Receipt Provided
Jun 20, 2023
Application Extension To Response Period - Received
Mar 21, 2023
Notification Of Non-Final Action E-Mailed
Mar 21, 2023
Non-Final Action E-Mailed
Mar 21, 2023
Non-Final Action Written
Mar 10, 2023
Assigned To Examiner
Jun 2, 2022
Notice Of Design Search Code E-Mailed
Jun 1, 2022
New Application Office Supplied Data Entered
May 28, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24